A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2023-08-27
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effect of BMS-986196 on the drug levels of caffeine,
montelukast, flurbiprofen, omeprazole, midazolam, digoxin, and pravastatin in healthy
participants.